Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)

STO:NEWBRY Ratios and Metrics

Market cap in millions SEK. Fiscal year is September - August.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 24, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Market Cap	79	63	80	78	76	-
Market Cap Growth	-3.70%	-20.86%	2.52%	2.15%	-	-
Enterprise Value	64.36	48.79	64.75	69.56	43.11	0
Last Close Price	2.60	2.59	3.30	4.00	4.44	-
Forward PE	-	13.45	-	-	-	-
PS Ratio	2.26	1.85	2.01	6.99	10.56	-
EV/Sales Ratio	1.84	1.43	1.63	6.23	5.95	-
Net Debt / Equity Ratio	-	-	-	-	-	-0.34
Net Debt / EBITDA Ratio	0.59	0.66	1.09	0.44	2.27	2.34
Net Debt / FCF Ratio	0.75	1.18	0.65	0.37	2.22	3.23
Asset Turnover	0.45	0.41	0.49	0.14	0.11	0.13
Inventory Turnover	2.08	2.68	5.86	3.26	4.46	-
Quick Ratio	0.73	1.21	1.32	2.14	5.73	3.57
Current Ratio	1.00	1.51	1.49	2.31	6.02	3.63
Return on Equity (ROE)	-84.80%	-49.27%	-30.43%	-32.89%	-27.35%	-28.89%
Return on Assets (ROA)	-30.44%	-25.80%	-17.19%	-24.51%	-22.61%	-26.26%
Return on Invested Capital (ROIC)	-149.40%	-66.98%	-36.36%	-51.35%	-48.28%	-22.20%
Return on Capital Employed (ROCE)	-71.34%	-40.71%	-22.97%	-27.59%	-24.59%	-29.22%
Buyback Yield / Dilution	-24.43%	-25.40%	-24.39%	-0.60%	-25.19%	-
Total Shareholder Return	-24.43%	-25.40%	-24.39%	-0.60%	-25.19%	-

Data Source: Fiscal.ai Last updated: Jul 8, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 24, 2026

Data Sources Report a data error